IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity
Zhao, Xiaosu1,2,3; Yan, Chenhua1; Liu, Daihong1; Xu, Lanping1; Liu, Yanrong1; Liu, Kaiyan1; Qin, Yazhen1; Wang, Yu1; Huang, Xiaojun1
关键词Wt1 Minimal Residual Disease Relapse Allogeneic Hematopoietic Stem Cell Transplant
刊名LEUKEMIA & LYMPHOMA
2013-06-01
suppl.1页:6-6
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology ; Hematology
研究领域[WOS]Oncology ; Hematology
语种英语
WOS记录号WOS:000320066300011
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51251
专题北京大学第二临床医学院
作者单位1.Peking Univ, Inst Hematol, Beijing, Peoples R China
2.Peking Univ, Peoples Hosp, Beijing, Peoples R China
3.Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Xiaosu,Yan, Chenhua,Liu, Daihong,et al. Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity[J]. LEUKEMIA & LYMPHOMA,2013,suppl.1:6-6.
APA Zhao, Xiaosu.,Yan, Chenhua.,Liu, Daihong.,Xu, Lanping.,Liu, Yanrong.,...&Huang, Xiaojun.(2013).Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity.LEUKEMIA & LYMPHOMA,suppl.1,6-6.
MLA Zhao, Xiaosu,et al."Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity".LEUKEMIA & LYMPHOMA suppl.1(2013):6-6.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Xiaosu]的文章
[Yan, Chenhua]的文章
[Liu, Daihong]的文章
百度学术
百度学术中相似的文章
[Zhao, Xiaosu]的文章
[Yan, Chenhua]的文章
[Liu, Daihong]的文章
必应学术
必应学术中相似的文章
[Zhao, Xiaosu]的文章
[Yan, Chenhua]的文章
[Liu, Daihong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。